Vertex faces regulatory delays for Journavx and reports VX-993 Phase 2 trial failure
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
Vasograin Plus represents a major advancement in the treatment of migraine
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Celecoxib is a nonsteroidal anti-inflammatory drug
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
Subscribe To Our Newsletter & Stay Updated